HomeCompaniesProfile

Engage Bio

mRNA Immunotherapies to Eliminate Cancer 


Company Size

1 - 5 employees

Year Founded

2021


About Engage Bio

Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.

Founders & Key People

Will Olsen

Will Olsen

Founder, Engage Bio

Kathryn Kwant

Kathryn Kwant

Founder, Engage Bio

Share This Profile

More Companies

Cosmic

Cosmic is a headless CMS and API toolkit

Genomelink

DNA App Store

Accord

Driving execution excellence for B2B Sales, Onboarding, and CS

Gradia Health

Integrated, high touch healthcare — at scale

Clear Gene

Our tests help eradicate cancer by telling doctors whether they got…

Shaped

The fastest path to relevant recommendations and search

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.